Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NXT Biologics Inc
Profile last edited on: 10/19/21      CAGE: 850V7      UEI: MB9ADR23X1L8

Business Identifier: therapeutics for lung infections and respiratory illnesses
Year Founded
2018
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2391 Lakewood Manor Drive
Athens, GA 30606
   412-736-8072
   N/A
   N/A
Location: Single
Congr. District: 10
County: Clarke

Public Profile

NXT Biologics Inc, spun out of University of Georgia, develops therapeutics for lung infections and respiratory illnesses. One of the company's initial focuses is pneumocystis pneumonia, a fungal disease that severely affects immunocompromised people. The firm has developed a vaccine to treat this disease that uses recombinant proteins to boost immunity.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$272,439
Phase II Dollars
$0
Total Awarded
$272,439

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
0
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 1 NIH $272,439
Project Title: Development of a Vaccine to Prevent Pneumocystis Pneumonia

Key People / Management

  Michael Robert Downes

Company News

There are no news available.